EGFR and lung cancer: The major clinicopathological characteristics including demographic information, Eastern Cooperative Oncology Group performance status (ECOG PS), smoking history, lung cancer histology (WHO classification30, number of BM, sites of extra-bone metastasis, EGFR mutation status, time of BM diagnosis, and SREs were all collected.